Submit Deal
All Dealmakers
Similar Dealmakers
CEO at PERCEPTIVE ADVISORS LLC
Investor
Share Profile
Deal Bio
Market Context
Awards
Back to top
All rights reserved. Copyright © 2025 Datasite
Expertise (30)
Key Relationships
Sort
Target: AXIS THERAPEUTICS LIMITED
Bidder: ATHENEX INC
6 Service Providers
6 Dealmakers
n/a
Value
Target: NUVATION BIO INC
Bidder: BAUPOST GROUP
13 Service Providers
13 Dealmakers
£ 214 M
Target: FREENOME
Bidder: T. ROWE PRICE GROUP INC
17 Service Providers
30 Dealmakers
£ 126 M
Target: POSEIDA THERAPEUTICS
Bidder: VIVO CAPITAL LLC
11 Service Providers
12 Dealmakers
£ 109 M
Target: IMMATICS BIOTECHNOLOGIES GMBH
Bidder: ARYA SCIENCES ACQUISITION CORP
23 Service Providers
73 Dealmakers
£ 288 M
Target: ATEA PHARMACEUTICALS INC
Bidder: ALLY BRIDGE GROUP
15 Service Providers
27 Dealmakers
£ 175 M
Target: ARCHERDX
Bidder: INVITAE
56 Dealmakers
£ 1.13 B
Target: CEREVEL THERAPEUTICS
Bidder: ECOR1 CAPITAL
27 Service Providers
66 Dealmakers
£ 1.00 B
Target: KRONOS BIO
Bidder: PERCEPTIVE ADVISORS LLC
18 Service Providers
18 Dealmakers
£ 118 M
Target: I-MAB
Bidder: HILLHOUSE CAPITAL GROUP
33 Dealmakers
£ 315 M
Target: C4 THERAPEUTICS INC
Bidder: RTW INVESTMENTS
16 Service Providers
26 Dealmakers
£ 119 M
Bidder: PANACEA ACQUISITION CORP
34 Dealmakers
£ 650 M
Target: COMPASS PATHWAYS
Bidder: CAMDEN PARTNERS NEXUS
7 Service Providers
7 Dealmakers
£ 64 M
Target: THRIVE EARLIER DETECTION CORP
Bidder: EXACT SCIENCES
61 Dealmakers
£ 1.65 B
Target: ZYMERGEN
Bidder: BAILLIE GIFFORD & CO
5 Service Providers
9 Dealmakers
£ 230 M
Target: DAY ONE BIOPHARMACEUTICALS
Bidder: RA CAPITAL MANAGEMENT
11 Dealmakers
£ 94 M
Target: ABSCI
Bidder: CASDIN CAPITAL
8 Service Providers
£ 90 M
Target: SOMALOGIC
Bidder: JANUS HENDERSON INVESTORS
22 Service Providers
63 Dealmakers
£ 891 M
Target: IMMUNEERING CORPORATION
9 Service Providers
14 Dealmakers
£ 44 M
Target: CROSSOVER HEALTH
£ 121 M
Target: ICOSAVAX INC
Bidder: SANOFI VENTURES
19 Dealmakers
£ 71 M
Target: AFFINIA THERAPEUTICS
15 Dealmakers
£ 80 M
Target: HONOR
8 Dealmakers
£ 273 M
Target: TWIN HEALTH
Bidder: LTS INVESTMENTS
10 Dealmakers
£ 103 M
Target: CINCOR PHARMA
Bidder: BVF PARTNERS
£ 104 M
Target: ENDEAVOR BIOMEDICINES
10 Service Providers
£ 74 M
Target: DNANEXUS
Bidder: NORTHPOND VENTURES
£ 151 M
Target: ZENAS BIOPHARMA
Bidder: AGENT CAPITAL
Target: ONKURE THERAPEUTICS
Bidder: SURVEYOR CAPITAL
£ 43 M
Target: CARIS LIFE SCIENCES
Bidder: BRAIDWELL LP
£ 130 M
